| [1] |
Al Hajj M,Wicha MS,Benito HA,et al.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA,2003,100:3983-3988.
|
| [2] |
Shackleton M,Vaillant F,Simpson KJ,et al.Generation of a functional mammary gland from a single stem cell.Nature,2006,439:84-88.
|
| [3] |
Woodward WA,Chen MS,Behbod F,et al.On mammary stem cells.J Cell Sci,2005,118:3585-3594.
|
| [4] |
Smalley M,Ashworth A.Stem cells and breast cancer:A field in transit.Nat Rev Cancer,2003,3:832-844.
|
| [5] |
Passegue E,Jamieson CH,Ailles LE,et al.Normal and leukemic hematopoiesis:are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?Proc Natl Acad Sci USA,2003,100:11 842-11 849.
|
| [6] |
Willert K,Brown JD,Danenberg E,et al.Wnt proteins are lipid-modified and can act as stem cell growth factors.Nature,2003,423:448-452.
|
| [7] |
Reya T,Duncan AW,Ailles L,et al.A role for Wnt signaling in self-renewal of haematopoietic stem cells.Nature,2003,423:409-414.
|
| [8] |
Cariati M,Naderi A,Brown JP,et al.Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF-7 breast cancer cell line.Int J Cancer,2008,122:298-304.
|
| [9] |
Phillips TM,McBride WH,Pajonk F.The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.J Natl Cancer Inst,2006,98:1777-1785.
|
| [10] |
Donnenberg VS,Donnenberg AD.Multiple drug resistance in cancer revisited:the cancer stem cell hypothesis.J Clin Pharmacol,2005,45:872-877.
|
| [11] |
Dean M,Fojo T,Bates S.Tumour stem cells and drug resistance.Nat Rev Cancer,2005,5:275-284.
|
| [12] |
Abraham BK,Fritz P,McClellan M,et al.Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.Clin Cancer Res,2005,11:1154-1159.
|
| [13] |
Shipitsin M,Campbell LL,Argani P,et al.Molecular definition of breast tumor heterogeneity.Cancer Cell,2007,11:259-273.
|
| [14] |
Dontu G,Al-Hajj M,Abdallah WM,Clarke MF,et al.Stem cells in normal breast development and breast cancer.Cell Prolif,2003,36:59-72.
|
| [15] |
齐晓伟.三阴性乳腺癌研究进展.中华乳腺病杂志:电子版,2008,2:612-617.
|
| [16] |
Goodell MA,Brose K,Paradis G,et al.Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.J Exp Med,1996,183:1797-1806.
|
| [17] |
Sleeman KE,Kendrick H,Ashworth A,et al.CD24 staining of mouse mammary gland cells defines luminal epithelial,myoepithelial/basal and non-epithelial cells.Breast Cancer Res,2006,8:R7.
|
| [18] |
Alvi AJ,Clayton H,Joshi C,et al.Functional and molecular characterization of mammary side population cells.Breast Cancer Res,2003,5:R1-R8.
|
| [19] |
Zhou S,Schuetz JD,Bunting KD,et al.The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.Nat Med,2001,7:1028-1034.
|
| [20] |
Zhou J,Wulfkuhle J,Zhang H,et al.Activation of the PTEN/mTOR/STAT 3 pathway in breast cancer stem-like cells is required for viability and maintenance.Proc Natl Acad Sci USA,2007,104:16 158-16 163.
|
| [21] |
Ginestier C,Hur MH,Charafe Jauffret E,et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell,2007,1:555-567.
|
| [22] |
Philip AB,Sunil SK,David MB.Tissue repair and stem cell renewal in carcinogenesis.Nature,2004,432:324-331.
|
| [23] |
Liu S,Dontu G,Wicha MS.Mammary stem cells,self-renewal pathways,and carcinogenesis.Breast Cancer Res,2005,7:86-95.
|
| [24] |
Li Y,Welm B,Podsypanina K,et al.Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.Proc Natl Acad Sci USA,2003,100:15 853-15 858.
|
| [25] |
Dontu G,Jackson KW,McNicholas E,et al.Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.Breast Cancer Res,2004,6:R605-R615.
|
| [26] |
Bouras T,Pal B,Vaillant F,et al.Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.Cell Stem Cell,2008,3:429-441.
|
| [27] |
Korkaya H,Paulson A,Iovino F,et al.HER-2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.Oncogene,2008,27:6120-6130.
|
| [28] |
Bedard PL,Cardoso F,Piccart Gebhart MJ.Stemming resistance to HER-2 targeted therapy.J Mammary Gland Biol Neoplasia,2009,14:55-66.
|